Euglycemic DKA: It Is Not a Myth

Author(s): Roff Heather A

Contact Hours 1.00

CERP A 1.00

Pharmacology Hours 0.40

Expires Dec 31, 2024

Topics: Endocrine, Pharmacology

Population: Adult

Role: APRN

Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Euglycemic DKA is a life-threatening endocrine emergency often under-recognized due to the unusual presentation without severe hyperglycemia. Delays in identifying and initiating treatment for this condition can lead to severe metabolic acidosis. This advanced session employs case studies to provide an in-depth pharmacologic review of the most likely causative agents of euglycemic DKA, with tips on differential diagnoses and treatment pathways to stabilize this endocrine emergency. Pharmacology content = 40%.


  • Identify risk factors which contribute to the development of euglycemic DKA, including pharmacologic review of SGLT2 inhibitors.
  • List differential diagnosis and confounders of euglycemic DKA.
  • Illustrate the pharmacologic management of euglycemic DKA using case studies.

Continuing Education Disclosure Statement

Successful Completion

Learners must attend/view/read the entire activity and complete the associated evaluation to be awarded the contact hours or CERP. No partial credit will be awarded.


This activity has been reviewed by the Nurse Planner. It has been determined that the material presented here shows no bias. No conflicts of interest have been identified for any individual with the ability to influence the content of this activity. Accreditation refers to recognition of continuing education only and does not imply AACN or ANCC approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity.


The American Association of Critical-Care Nurses (AACN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's (ANCC's) Commission on Accreditation, ANCC Provider Number 0012. AACN has been approved as a provider of continuing education in nursing by the California State Board of Nursing (CBRN), California Provider number CEP 1036. This activity is approved for 1.00 contact hours.

AACN programming meets the standards for most states that require mandatory continuing education contact hours for license and/or certification renewal. AACN recommends consulting with your state board of nursing or credentialing organization before submitting CE to fulfill continuing education requirements.

Refund Policy

Continuing Education Activities are nonrefundable.